Korea Investment CORP Makes New Investment in Corteva, Inc. $CTVA

Korea Investment CORP purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 279,853 shares of the company’s stock, valued at approximately $23,701,000.

Other hedge funds have also modified their holdings of the company. JPL Wealth Management LLC purchased a new position in shares of Corteva in the third quarter worth about $25,000. Garton & Associates Financial Advisors LLC purchased a new position in Corteva during the 4th quarter worth approximately $27,000. Bank of Jackson Hole Trust acquired a new stake in Corteva during the 4th quarter valued at approximately $28,000. Cornerstone Financial Management LLC purchased a new stake in shares of Corteva in the 4th quarter valued at $29,000. Finally, Elevation Wealth Partners LLC increased its stake in shares of Corteva by 334.6% in the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after acquiring an additional 261 shares during the period. 81.54% of the stock is owned by institutional investors and hedge funds.

Get Corteva alerts:

Corteva Price Performance

NYSE:CTVA opened at $81.84 on Monday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The company has a 50 day moving average price of $82.13 and a 200-day moving average price of $80.26. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97. The firm has a market cap of $54.60 billion, a price-to-earnings ratio of 54.20, a price-to-earnings-growth ratio of 2.51 and a beta of 0.57.

Corteva (NYSE:CTVA – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The firm had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio is 47.68%.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Morgan Stanley raised their target price on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. CICC Research upped their price target on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. UBS Group cut their price target on Corteva from $89.00 to $85.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 18th. JPMorgan Chase & Co. lifted their price objective on Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $101.00 price objective on shares of Corteva in a report on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $91.50.

Check Out Our Latest Stock Report on CTVA

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

See Also

• Five stocks we like better than Corteva
• VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
• 3 Closed-End Funds to Maximize Dividend Payments
• Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
• $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.